Abstract
Objective: The objective of the study is to estimate the burden of tuberculosis (TB) patients, both pulmonary and extra-pulmonary, presenting to a tertiary care hospital in southern Rajasthan and to understand the resistance pattern among them.
Methods: It is a retrospective observational study. The duration of the study was 3 years (January 2021–December 2023). Data were collected from TB registers maintained by the respiratory medicine department. The inclusion criteria were all suspected TB patients (pulmonary and extra-pulmonary). Both microbiologically confirmed and clinically diagnosed TB patients were included in the study.
Results: The total number of sputum samples received of suspected pulmonary TB patients was 1923, out of which 600 (31.2%) were acid–fast bacilli (AFB) smear positive. The total number of samples received for CBNAAT testing was 1292, out of which 266 (20.59%) were CBNAAT positive. Total multidrug-resistant (MDR) TB patients were 58 (49 pulmonary TB and 9 extra-pulmonary TB (EPTB) [5 lymph, 3 pleural, and 1 bone]). The percentage of MDR-pulmonary TB patients among total sputum samples tested was 2.55%. The total number of pulmonary TB patients diagnosed was 1016 (microbiologically confirmed 866 + clinically diagnosed 150). Total EPTB patients diagnosed were 805 (microbiologically confirmed 141 + clinically diagnosed 664).
Conclusion: 31.2% of total sputum samples tested of suspected pulmonary TB patients were AFB smear positive, and 20.59% were CBNAAT positive. Most of the patients diagnosed with EPTB were diagnosed on a clincoradiological basis. The percentage of MDR–PTB among all sputum samples tested was 2.55%.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference11 articles.
1. Hetmann DL. Control of Communicable Disease Manual. 18th ed. Washington, DC: APHA; 2004. p. 560-72.
2. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362(9387):887-9. doi: 10.1016/S0140-6736(03)14333-4, PMID 13678977
3. Youmans G. Tuberculosis. Philadelphia, PA: W. B. Saunders Company; 1979.
4. Institute of Medicine (US). Drug-resistant TB in India. In: Facing the Reality of Drug-resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Ch. 2. Washington, DC: National Academies Press US; 2012.
5. Dutt R, Singh R, Majhi J, Basu G. Status of drug resistant tuberculosis among patients attending a tuberculosis unit of West Bengal: A record based cross-sectional study. J Family Med Prim Care. 2022 Jan;11(1):84-9. doi: 10.4103/jfmpc.jfmpc_576_21, PMID 35309659